These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21576813)

  • 1. Value of diffusion-weighted imaging for assessing site-specific response of advanced ovarian cancer to neoadjuvant chemotherapy: correlation of apparent diffusion coefficients with epithelial and stromal densities on histology.
    Kyriazi S; Nye E; Stamp G; Collins DJ; Kaye SB; deSouza NM
    Cancer Biomark; 2010; 7(4):201-10. PubMed ID: 21576813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Sharma U; Danishad KK; Seenu V; Jagannathan NR
    NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
    Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
    Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteosarcoma: preliminary results of in vivo assessment of tumor necrosis after chemotherapy with diffusion- and perfusion-weighted magnetic resonance imaging.
    Uhl M; Saueressig U; van Buiren M; Kontny U; Niemeyer C; Köhler G; Ilyasov K; Langer M
    Invest Radiol; 2006 Aug; 41(8):618-23. PubMed ID: 16829744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced ovarian cancer: multiparametric MR imaging demonstrates response- and metastasis-specific effects.
    Sala E; Kataoka MY; Priest AN; Gill AB; McLean MA; Joubert I; Graves MJ; Crawford RA; Jimenez-Linan M; Earl HM; Hodgkin C; Griffiths JR; Lomas DJ; Brenton JD
    Radiology; 2012 Apr; 263(1):149-59. PubMed ID: 22332064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting response to neoadjuvant chemoradiation therapy in locally advanced rectal cancer: diffusion-weighted 3 Tesla MR imaging.
    Jung SH; Heo SH; Kim JW; Jeong YY; Shin SS; Soung MG; Kim HR; Kang HK
    J Magn Reson Imaging; 2012 Jan; 35(1):110-6. PubMed ID: 21989997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian adenofibromas and cystadenofibromas: magnetic resonance imaging findings including diffusion-weighted imaging.
    Takeuchi M; Matsuzaki K; Harada M
    Acta Radiol; 2013 Mar; 54(2):231-6. PubMed ID: 23171527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of diffusion-weighted echo-planar MR imaging and ADC mapping in the evaluation of residual cervical carcinoma after radiation therapy.
    Levy A; Caramella C; Chargari C; Medjhoul A; Rey A; Zareski E; Boulet B; Bidault F; Dromain C; Balleyguier C
    Gynecol Oncol; 2011 Oct; 123(1):110-5. PubMed ID: 21764110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion-weighted magnetic resonance imaging of uterine cervical cancer.
    Liu Y; Bai R; Sun H; Liu H; Wang D
    J Comput Assist Tomogr; 2009; 33(6):858-62. PubMed ID: 19940650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment.
    Belli P; Costantini M; Ierardi C; Bufi E; Amato D; Mule' A; Nardone L; Terribile D; Bonomo L
    Breast J; 2011; 17(6):610-9. PubMed ID: 21929557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease.
    Ferron JG; Uzan C; Rey A; Gouy S; Pautier P; Lhommé C; Duvillard P; Morice P
    Eur J Obstet Gynecol Reprod Biol; 2009 Nov; 147(1):101-5. PubMed ID: 19740592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging in predicting and monitoring the response of uterine cervical cancer to combined chemoradiation.
    Liu Y; Bai R; Sun H; Liu H; Zhao X; Li Y
    Clin Radiol; 2009 Nov; 64(11):1067-74. PubMed ID: 19822239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Water mobility of diffusion MRI in prediction of response to chemoembolization in liver cancer].
    Yuan Z; Ye XD; Dong S; Xu LC; Sun ZC; Xiao XS
    Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):293-7. PubMed ID: 19615287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
    Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
    J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary results of neoadjuvant chemotherapy with paclitaxel and cisplatin in patients with advanced epithelial ovarian cancer who are inadequate for optimum primary surgery.
    Lee SJ; Kim BG; Lee JW; Park CS; Lee JH; Bae DS
    J Obstet Gynaecol Res; 2006 Feb; 32(1):99-106. PubMed ID: 16445534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy versus primary debulking surgery in advanced ovarian cancer.
    Vergote IB; De Wever I; Decloedt J; Tjalma W; Van Gramberen M; van Dam P
    Semin Oncol; 2000 Jun; 27(3 Suppl 7):31-6. PubMed ID: 10952124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance diffusion-weighted imaging: extraneurological applications.
    Colagrande S; Carbone SF; Carusi LM; Cova M; Villari N
    Radiol Med; 2006 Apr; 111(3):392-419. PubMed ID: 16683086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.